Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Oct 1;10(19):2864-6.
doi: 10.3748/wjg.v10.i19.2864.

Low plasma apolipoprotein A-I level is not a reliable marker of fibrosis in children with chronic hepatitis B

Mukadder-Ayse Selimoglu  1 , Rasit-Vural Yagcl, Gül Yüce
Affiliations

Low plasma apolipoprotein A-I level is not a reliable marker of fibrosis in children with chronic hepatitis B

Mukadder-Ayse Selimoglu et al. World J Gastroenterol. .

Abstract

Aim: To evaluate the clinical value of plasma apolipoprotein A-I (Apo A-I) as a marker of fibrosis in children with chronic hepatitis B (CHB).

Methods: Liver biopsy specimens from 49 children with CHB were evaluated by using Knodell index. Plasma Apo A-I level was measured after 12-h fasting. Student's t test, Spearman's correlation test and receptor-operating characteristic (ROC) curve were used for statistical evaluation.

Results: Mean Apo A-I level of the patients was not different from that of controls (P>0.05). Six (8.7%) children had fibrosis score of more than 2 (severe fibrosis). No difference in the level of mean plasma Apo A-I was found among children with and without severe fibrosis (P>0.05). No correlation between Apo A-I level and fibrosis scores was found (P>0.05). The area under the ROC curve was 0.407+/-0.146 (P>0.05).

Conclusion: Severe fibrosis is not common in children with CHB and plasma Apo A-I level is not a reliable indicator of fibrosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROC curve of Apo A-I.
See this image and copyright information in PMC

References

    1. Paradis V, Laurent A, Mathurin P, Poynard T, Vidaud D, Vidaud M, Bedossa P. Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes. Cell Mol Biol (Noisy-le-grand) 1996;42:525–534. - PubMed
    1. Paradis V, Mathurin P, Ratziu V, Poynard T, Bedossa P. Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix. Hepatology. 1996;23:1232–1238. - PubMed
    1. Selimoğlu MA, Aydoğdu S, Yağci RV. Low plasma apolipoprotein A-I level: new prognostic criterion in childhood cirrhosis. Turk J Pediatr. 2001;43:307–311. - PubMed
    1. Selimoglu MA, Aydogdu S, Yagci RV. Lipid parameters in childhood cirrhosis and chronic liver disease. Pediatr Int. 2002;44:400–403. - PubMed
    1. Myers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol. 2002;97:2419–2425. - PubMed